期刊文献+

血宁片和多糖铁复合物胶囊两种口服铁剂在治疗维持性血液透析患者肾性贫血中的治疗效果评价 被引量:3

Xue Ning Tablet and Polysaccharide Iron Complex Capsule Two Oral Iron on Maintenance of Hemodialysis Patients With Renal Anemia and Its Therapeutic Effect Evaluation
下载PDF
导出
摘要 目的:对血宁片和多糖铁复合物胶囊在维持性血液透析肾性贫血患者中的治疗效果进行调查。方法选择我院2013年5月~2015年5月间68例进行维持性血液透析后发生肾性贫血的患者,根据患者自身意愿将其分为两组,比较两组患者的治疗效果。结果实验组患者治疗后SF、TSAT、Hb、Hct水平明显高于对照组,两组比较P<0.05。对照组有2例恶心、1例腹泻病例;实验组有1例腹泻、1例呕吐病例,两组比较无明显差异,P>0.05,χ2=1.32。结论血宁片在本病中的疗效更为显著,能够纠正患者病情。 Objective To Xue Ning tablet and polysaccharide iron complex capsule in the maintenance of hemodialysis patients with renal anemia treatment effect were investigated.Methods Patients with renal anemia occurred in our hospital from May 2013 to May 2015, 68 patients with renal anemia were divided into two groups according to their own wil, the treatment effect of the two groups were compared.ResultsThe levels of TSAT, Hb, Hct and SF in the experimental group were significantly higher than those in the control group, and the two groups were compared with P〈0.05. The control group had 2 cases of nausea, 1 cases of diarrhea, the experimental group had 1 cases of diarrhea, 1 cases of vomiting, the difference between the two groups,P〉0.05,χ2=1.32.Conclusion The curative effect on the disease of the blood tablet is more significant, can correct the patient's condition.
作者 荆婷婷
机构地区 郑州市中医院
出处 《中国卫生标准管理》 2015年第26期121-122,共2页 China Health Standard Management
基金 郑州市公关科技项目号(142102310166)
关键词 血宁片 维持性血液透析 肾性贫血 Shengxuening Hemodialysis Renal anemia
  • 相关文献

参考文献3

二级参考文献31

  • 1倪兆慧,钱家麒,丁小强,梅长林,袁伟杰,张金元,陈江华,邢昌赢,刘必成.蔗糖铁注射液治疗维持性血液透析患者肾性贫血的前瞻性、随机对照多中心研究[J].中华肾脏病杂志,2006,22(3):143-148. 被引量:114
  • 2Regidor DL, Kopple JD, Kovesdy CP, et al. Associations between changes in hemoglobin and administered erythropoiesisstimulating agent and survival in hemodialysis patients [J]. JAm Soc Nephrol,2006,17(4) :1181-1191. 被引量:1
  • 3KDOQI, National Kidney Furdnation. Ⅱ. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults [J]. Am J Kidney Dis, 2006, 47(5 Suppl 3) :S16-S85. 被引量:1
  • 4Collins A J, Li S,Ebben J, et al. Hematocrit levels and associat- ed Medicare expenditures [J]. Am J Kidney Dis, 2000,36 (2) :282-293. 被引量:1
  • 5Lankhorst CE,Wish JB. Anemia in renal disease:diagnosis and management[J]. Blood Rev ,2010,24( 1 ) :39-47. 被引量:1
  • 6Kanbay M, Perazella MA, Kasapoglu B, et al. Erythropoiesis stimulatory agent-resistant anemia in dialysis patients:review of causes and management[J]. Blood Purif,2010,29 ( 1 ) : 1-12. 被引量:1
  • 7Priyadarshi A, Shapiro Jl. Erythropoietin resistance in the treatment of the anemia of chronic renal failure [J]. Semin Dial, 2006,19(4) :273-278. 被引量:1
  • 8Garneata L. Intravenous iron, inflammation, and oxidative stress: is iron a friend or an enemy of uremic patients [J]. J Ren Nutr,2008,18 ( 1 ) :40-45. 被引量:1
  • 9Kalantar-Zadeh K, Streja E, Miller JE, et al. Intravenous iron versus erythropoiesis-stimulating agents:friends or foes in treating chronic kidney disease anemia [J]. Adv Chronic Kidney Dis,2009,16(2) :143-151. 被引量:1
  • 10Fishbane S. Iron supplementation in renal anemia [J]. Semin Nephrol, 2006,26 ( 4 ) : 319-324. 被引量:1

共引文献30

同被引文献52

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部